Jamie M. Stagl

TL;DR: Although no reliable estimate of adherence to oral antineoplastic therapies can be gleaned from the literature, a substantial proportion of patients struggle to adhere to these medications as prescribed, limiting the evidence to guide practice in promoting medication adherence among patients with cancer.

TL;DR: In early-stage breast cancer patients, a 10-week CBSM intervention can reverse anxiety-related upregulation of pro-inflammatory gene expression in circulating leukocytes, clarifying the molecular signaling pathways by which behavioral interventions can influence physical health and alter peripheral inflammatory processes that may reciprocally affect brain affective and cognitive processes.

TL;DR: Patients with incurable cancer face many physical and emotional stressors, yet little is known about their coping strategies or the relationship between their cope strategies, quality of life (QOL), and mood.

TL;DR: This 8‐ to 15‐year follow‐up of a previously conducted trial (NCT01422551) evaluated whether women in this cohort receiving CBSM had fewer depressive symptoms and better QOL than controls at an 8- to 15-year follow-up.

TL;DR: It is demonstrated that patients' coping strategies and prognostic understanding were associated with FC depression and anxiety symptoms, underscoring the importance of targeting these risk factors when seeking to address the psychological distress experienced by FCs.